Top Markets
Coin of the day
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Ранг среди акций #20516
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Цена акции
$20.27
Рыночная капитализация
$128.37M
Изменение (1 день)
-1.37%
Изменение (1 год)
79.91%
Страна
PL
Торговля Captor Therapeutics Spolka Akcyjna (CTX)

Категория

История цены акций Captor Therapeutics Spolka Akcyjna (CTX)
Наивысшая цена закрытия: $20.24 2026-08-01

Наименьшая цена закрытия: $45.81 2021-04-01
История цены акций Captor Therapeutics Spolka Akcyjna с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -1.93%
2025 68.95%
2024 -54.45%
2023 -32.61%
2022 -15.45%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.27 -15.19%
AU
$767.85 8.65%
CH